newsfilter
← Latest News
PR Newswire·

Aeglea BioTherapeutics to Participate in Upcoming November Investor Conferences

Aeglea BioTherapeutics, Inc. ("Aeglea") (Nasdaq: AGLE), a biotechnology company advancing a pipeline of antibody therapeutics with the potential to...